IAP-based biodegraders can convert necroptosis to apoptosis and eliminate cancer driving protein complexes
Ma X., Vaillant F., Gopal D., Schoffer K., Shojaee F., Pang J., Baldwin C. A., Murphy J. M., Silke J., Tanzer M. C., Visvader J. E., Salvamoser R., Vince J. E.
Cell Chem Biol. 2026, S2451-9456(26)00075-9. Online ahead of print.
Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomas
Aussel A., Nemazanyy I., Vandenberghe A., Meola P., Dorat N., Paul R., Habbouche L., Exposito L., Nottet N., Petrilli V., Chiche E., Mounier N., Marchetti S., Chaveroux C., Ricci J-E., Chiche J.
SMARCA2/4-Dependent Chromatin Remodelling Establishes Gene Regulatory Programs in Early Human Embryos and Blastoids
van Knippenberg S. S. F. A., Tryfonos M., De Busscher J., Solis M., Lorent C., Girard O., Poovathingal S., Wojno M., Khodeer S., De Clercq J., Mikorska A., Smeers I., Wigerinck E., Meynen Y., Voet T., David L., Van de Velde H., Pasque V.
